1988
DOI: 10.1016/0360-3016(88)90261-1
|View full text |Cite
|
Sign up to set email alerts
|

Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloroplatinum II, 5 fluorouracil, and radiation therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

1990
1990
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…In adults with NPC, Atichartakarn et al (29), Bachouchi et al (30) and Onat et al (31) reported better survival with neoadjuvant CT and RT. Several studies also have tested neoadjuvant cisplatin-based CT in paediatric NPC.…”
Section: Discussionmentioning
confidence: 97%
“…In adults with NPC, Atichartakarn et al (29), Bachouchi et al (30) and Onat et al (31) reported better survival with neoadjuvant CT and RT. Several studies also have tested neoadjuvant cisplatin-based CT in paediatric NPC.…”
Section: Discussionmentioning
confidence: 97%
“…The use of chemotherapy in combination with radiation therapy in the treatment of nasopharyngeal carcinoma has been introduced in an attempt to reduce locoregional tumoral failure rates and systemic failure rates observed in patients with locoregionally advanced disease treated with radiation therapy alone, despite improved initial locoregional tumoral response rates [10][11][12][17][18][19]43,45]. Although the most effective chemotherapy regimens to be used and their proper timing with radiation therapy remain to be determined [46], improved locoregional tumoral response rates, reduced locoregional tumoral failure rates, and reduced systemic failure rates [46][47][48][49][50][51][52][53] as well as improved overall and progression-free survival [48] have been reported with cisplatincontaining neoadjuvant and concurrent combination chemotherapy regimens. In this study, the addition of chemotherapy correlated with a lower systemic failure rate and an improved metastases-free survival.…”
Section: Discussionmentioning
confidence: 99%
“…Neoadjuvant chemotherapy was tried to reduce tumor burden before RT and to eradicate micro-metastases. Several phase II trials showed high overall response rate of cisplatin-based combination chemotherapy ranging from 75% to 90% [ 18 19 20 ]. However, prospective randomized trials failed to demonstrate improvement in survival [ 21 22 23 ].…”
Section: Discussionmentioning
confidence: 99%